What happened
Researchers from the UCL EGA Institute for Women’s Health reviewed the promises and limits of reproductive health technology. Their central warning is not that the category lacks potential, but that accuracy, clinical validity and care-pathway integration remain uneven.
Why it matters
A persuasive interface can look like clinical certainty. Independent validation, representative datasets and explicit escalation routes are essential when technology influences fertility or reproductive-health decisions.
What to watch
Prospective outcome studies, transparent performance reporting across populations, regulator expectations and evidence that products improve more than engagement.
